Biomedical Engineering Reference
In-Depth Information
HO
n
-BuLi, Et
2
O
5 min at -78°C
and 1 h at 0°C
OH
O
O
O
TBS
O
92%
O
O
O
O
(+)-Xestoquinone
SCHEME 8.29
[1,2]-Wittig rearrangement
as
a key step in the
synthesis of
(
þ
)-xestoquinone.
KH, 18-crown-6
THF, 0°C to rt, 3 h
O
SnBu
3
OH
n
-SnBu
3
SnCH
2
I
86%
TESO
TESO
H
H
TBSO
TBSO
-BuLi, Hexane
-50°C to 0°C, 5 h
n
78%
O
O
OH
OMe
TESO
H
O
H
(-)-Candelalide A
TBSO
SCHEME 8.30
[2,3]-Wittig rearrangement as akeystep in the synthesis of (
)-candelalideA.
the voltage-gated potassium channel Kv1.3, is based on the [2,3]-Wittig rearrange-
ment shown in Scheme 8.30 [154] using the Still variant [150].
An asymmetric [2,3]-Wittig rearrangement on a dienolate of a chiral
b
-pyrrolidinyl-
g
-allyloxyl-
a
,
b
-unsaturated ester using (1
S
,2
R
,4
R
)-2-hydroxy-7,7-
dimethylbicyclo[2.2.1]heptane-1-carboxylic acid diisopropylamide as chiral
auxiliary has been applied successfully to prepare a key intermediate in a synthesis
of (
þ
)-eldanolide [155] (Scheme 8.31).
OR*
O
CON(
-Pr)
2
OH
i
Xylene
reflux , 3 h
94%
CON(
i
-Pr)
2
O
O
O
+
N
H
H
O
O
O
O
O
O
LDA
THF/ Hexane
-78°C, 6 h
90%
O
O
CON(
i
-Pr)
2
N
R* =
H
(ee = 93%)
(+)-Eldanolide
SCHEME 8.31
[2,3]-Wittig rearrangement for (
þ
)-eldanolide.
Search WWH ::
Custom Search